Overview

Fulvestrant in Premenopausal Women With Hormone Receptor-Positive Breast Cancer

Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the effectiveness and safety of fulvestrant in premenopausal women with advanced breast cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborators:
Beth Israel Deaconess Medical Center
Brigham and Women's Hospital
Lowell General Hospital
Massachusetts General Hospital
Treatments:
Estradiol
Fulvestrant
Hormones